Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
UNICANCER
Shanghai JMT-Bio Inc.
Peking University
CSPC Megalith Biopharmaceutical Co.,Ltd.
Sun Yat-sen University
Sun Yat-sen University
NRG Oncology
Ukrainian Society of Clinical Oncology
Eurofarma Laboratorios S.A.
Australasian Gastro-Intestinal Trials Group
Oslo University Hospital
Tyme, Inc
Sun Yat-sen University
Shanghai University of Traditional Chinese Medicine
Shanghai Jiao Tong University School of Medicine
Bristol-Myers Squibb
University of California, San Francisco
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Sun Yat-sen University
Shanghai Zhongshan Hospital
Sorrento Therapeutics, Inc.
Assiut University
Sun Yat-sen University
Blokhin's Russian Cancer Research Center
UNICANCER
Krankenhaus Nordwest
Federation Francophone de Cancerologie Digestive
Peking University
Krankenhaus Nordwest
Guangxi Medical University
Guangxi Medical University
University of Birmingham
Sun Yat-sen University
Instituto Nacional de Cancer, Brazil
Shandong Cancer Hospital and Institute
Peking University Cancer Hospital & Institute
European Organisation for Research and Treatment of Cancer - EORTC
AstraZeneca
Peking University
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
GBG Forschungs GmbH
UNICANCER
Fudan University
Sirtex Medical
Sun Yat-sen University
Tehran University of Medical Sciences
Sixth Affiliated Hospital, Sun Yat-sen University
CONKO-Studiengruppe
National Cancer Institute (NCI)